JUBILANT INGREVIA LIMITED Financials Jubilant Ingrevia Limited Bombay S.E.
Equities
JUBLINGREA
INE0BY001018
Specialty Chemicals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 515 INR | -1.54% |
|
-5.27% | +1.50% |
| 04-26 | Jubilant Ingrevia Raises INR1 Billion Via Commercial Paper Issue | MT |
| 04-17 | Jubilant Ingrevia Issues Commercial Papers Worth INR1 Billion | MT |
Valuation
| Fiscal Period: Marzo | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 71,653 | 57,333 | 83,336 | - | - |
| Enterprise Value (EV) 1 | 71,653 | 57,333 | 83,336 | 83,336 | 83,336 |
| P/E ratio | 15 x | 18.6 x | 41.3 x | 26 x | 20.4 x |
| Yield | - | 1.39% | 0.76% | 0.85% | 0.9% |
| Capitalization / Revenue | 1.45 x | 1.2 x | 2.03 x | 1.65 x | 1.46 x |
| EV / Revenue | 1.45 x | 1.2 x | 2.03 x | 1.65 x | 1.46 x |
| EV / EBITDA | 8.61 x | 10.5 x | 19.5 x | 14.3 x | 10.8 x |
| EV / FCF | 32.2 x | -303 x | -166 x | -125 x | 291 x |
| FCF Yield | 3.11% | -0.33% | -0.6% | -0.8% | 0.34% |
| Price to Book | - | 2.15 x | 2.97 x | 2.71 x | 2.43 x |
| Nbr of stocks (in thousands) | 159,281 | 159,281 | 159,281 | - | - |
| Reference price 2 | 449.8 | 360.0 | 523.2 | 523.2 | 523.2 |
| Announcement Date | 17/05/22 | 16/05/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Marzo | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 49,494 | 47,727 | 40,996 | 50,592 | 57,055 |
| EBITDA 1 | - | 8,318 | 5,471 | 4,277 | 5,823 | 7,682 |
| EBIT 1 | - | 7,084 | 4,249 | 3,225 | 4,951 | 6,177 |
| Operating Margin | - | 14.31% | 8.9% | 7.87% | 9.79% | 10.83% |
| Earnings before Tax (EBT) 1 | - | 7,089 | 4,368 | 3,073 | 4,658 | 6,290 |
| Net income 1 | 543.6 | 4,767 | 3,075 | 1,912 | 2,974 | 4,075 |
| Net margin | - | 9.63% | 6.44% | 4.66% | 5.88% | 7.14% |
| EPS 2 | - | 29.97 | 19.33 | 12.67 | 20.13 | 25.67 |
| Free Cash Flow 1 | - | 2,226 | -189.3 | -502.5 | -666.5 | 286.5 |
| FCF margin | - | 4.5% | -0.4% | -1.23% | -1.32% | 0.5% |
| FCF Conversion (EBITDA) | - | 26.76% | - | - | - | 3.73% |
| FCF Conversion (Net income) | - | 46.69% | - | - | - | 7.03% |
| Dividend per Share 2 | - | - | 5.000 | 4.000 | 4.450 | 4.700 |
| Announcement Date | 07/06/21 | 17/05/22 | 16/05/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: Marzo | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 12,865 | 12,958 | 11,658 | 13,036 | 11,583 | 11,450 | 10,750 | 10,716 | 9,395 | 10,354 |
| EBITDA 1 | - | 2,220 | 1,424 | 1,409 | 1,529 | 1,513 | 1,021 | 1,166 | 1,055 | 996.7 | 991.8 |
| EBIT 1 | - | - | - | 1,095 | - | - | - | 843.5 | - | 647 | 676.6 |
| Operating Margin | - | - | - | 9.39% | - | - | - | 7.85% | - | 6.89% | 6.53% |
| Earnings before Tax (EBT) | - | - | - | - | - | 1,216 | 755.1 | - | 707 | 651 | 601 |
| Net income 1 | 0.0111 | - | - | - | - | 915.3 | 523.1 | 575.9 | 706 | 446.7 | 474.6 |
| Net margin | - | - | - | - | - | 7.9% | 4.57% | 5.36% | 6.59% | 4.75% | 4.58% |
| EPS 2 | - | - | - | - | - | - | - | 3.630 | - | 2.800 | 2.900 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 19/10/21 | 01/02/22 | 17/05/22 | 05/08/22 | 20/10/22 | 31/01/23 | 16/05/23 | 26/07/23 | - | - | - |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: Marzo | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 2,226 | -189 | -503 | -667 | 287 |
| ROE (net income / shareholders' equity) | - | 21.9% | 12.1% | 11% | 15.6% | 12.7% |
| ROA (Net income/ Total Assets) | - | - | 7.63% | - | - | - |
| Assets 1 | - | - | 40,280 | - | - | - |
| Book Value Per Share 2 | - | - | 168.0 | 176.0 | 193.0 | 215.0 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 2,301 | 4,814 | 6,067 | 5,667 | 5,667 |
| Capex / Sales | - | 4.65% | 10.09% | 14.8% | 11.2% | 9.93% |
| Announcement Date | 07/06/21 | 17/05/22 | 16/05/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
523.2
INR
Average target price
557.3
INR
Spread / Average Target
+6.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.43% | 66.51B | |
| +1.24% | 48.47B | |
| +17.48% | 41.43B | |
| +22.33% | 27.19B | |
| +12.19% | 19.82B | |
| +4.74% | 18.15B | |
| -22.01% | 15.98B | |
| -8.95% | 15.46B | |
| +4.33% | 15.53B |
- Stock Market
- Equities
- JUBLINGREA Stock
- JUBLINGREA Stock
- Financials Jubilant Ingrevia Limited
